Unfortunately, even as a trail, this offers very little actual game. It is a teasingly tiny taster of the full product that doesn’t even let you finish the prologue. If you just want to make sure House of the Dead III will run on your machine then it is certainly worth a go, otherwise you will find it disappointingly short. Technically competent and kind of fun, this House of the Dead III Trial unfortunately comes up lacking thanks to its brevity and the concessions that have had to be made to bring it in to the home.OTTAWA - Canada is buying up to 1.5 million courses of oral antiviral treatments for COVID-19 in anticipation of them being approved by Health Canada. The government has signed up for an initial one million courses of antiviral treatment from Pfizer, once Health Canada endorses their safety and efficacy.The company submitted a request for approval to the federal drug regulator earlier this week.Ĭanada has also purchased 500,000 courses of Merck's oral antiviral treatment for COVID-19, with the option to purchase another 500,000 once Health Canada approves the drug. “Access to effective, easy-to-use treatments is critical to reducing the severity of COVID infections and will help save lives,” Procurement Minister Filomena Tassi said Friday.Ī stock of antiviral medications will complement vaccines in fighting the pandemic, she said. “It's just another tool in the tool box, but an important one,” she said. Some experts have hailed antiviral drugs as a game-changer in treating the disease, since they are designed to block the enzyme essential for viral replication. “If successful, oral antiviral therapies … may help to reduce the severity or onset of illness in adults who contract, or have been exposed to, COVID-19. An oral treatment option may thus be an important tool to help address the ongoing global impact of the COVID-19 pandemic,” Pfizer Canada's Kevin Mohamed said in a written statement Friday. Merck's clinical trial showed a 50 per cent reduced risk of hospitalization or death compared to placebo patients with mild or moderate COVID-19, for example. The oral medications will also be more accessible than the ones that need to be given intravenously, federal Health Minister Jean-Yves Duclos said Friday.Ĭurrent antivirals are only available to people in hospital, leaving them unavailable to people in remote regions or people with mild to moderate illness.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |